Biocryst Pharmaceuticals (BCRX) Change in Receivables (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) reported Change in Receivables of $1.49 million for Q2 2026, down 79.7% from $7.31 million a year earlier but up 213.3% from the prior quarter.
Biocryst Pharmaceuticals (BCRX) Change in Receivables (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Biocryst Pharmaceuticals' Change in Receivables came in at $17.47 million, down 45.2% year-over-year; for FY2025, it came in at $36.81 million, up 62.2% from FY2024.
- By year, Change in Receivables came in at $22.7 million in FY2024 (+272.4%), $6.1 million in FY2023 (-71.6%), $21.47 million in FY2022 (+3.1%) and $20.82 million in FY2021.
- Five-year quarterly Change in Receivables spans a low of -$3.84 million in Q3 2023 and a high of $15.49 million in Q4 2025.
- Year over year, Change in Receivables gained in three of the last seven quarters, with growth averaging 33.6%.
- The high point for year-over-year Change in Receivables in five years was Q1 2025 (growth of 264.3%); the low point was Q3 2025 (a decline of 99.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $474,000 (Q1 2026), $15.49 million (Q4 2025) and $17,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Biocryst Pharmaceuticals | 2.13 Bn | 1.05 Bn | 214.41 Mn | 1.49 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Mn |
| Mar 31, 2026 | 474,000.00 |
| Dec 31, 2025 | 15.49 Mn |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 7.31 Mn |
| Mar 31, 2025 | 13.99 Mn |
| Dec 31, 2024 | 7.30 Mn |
| Sep 30, 2024 | 3.32 Mn |
| Jun 30, 2024 | 8.25 Mn |
| Mar 31, 2024 | 3.84 Mn |
| Dec 31, 2023 | 2.97 Mn |
| Sep 30, 2023 | -3.84 Mn |
| Jun 30, 2023 | 8.99 Mn |
| Mar 31, 2023 | -2.02 Mn |
| Dec 31, 2022 | 7.64 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | 5.30 Mn |
| Mar 31, 2022 | 7.05 Mn |
| Dec 31, 2021 | 3.24 Mn |
| Sep 30, 2021 | -1.40 Mn |
Biocryst Pharmaceuticals Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=BCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();